If you believe it, sell BAL.I will remind you of your decision when this hits $12.BAL is ready to rerate, we just need good news.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025